[{"address1": "11 Great Valley Parkway", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 328 4701", "website": "https://www.ocugen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is involved in the development of OCU200, a novel fusion protein for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.", "fullTimeEmployees": 95, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shankar  Musunuri M.B.A., Ph.D.", "age": 60, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 1151298, "exercisedValue": 0, "unexercisedValue": 347968}, {"maxAge": 1, "name": "Dr. Uday B. Kompella Ph.D.", "age": 57, "title": "Co-founder & Independent Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 61875, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Arun  Upadhyay Ph.D.", "age": 42, "title": "Chief Scientific Officer and Head of Research & Development", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 649630, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Huma  Qamar CMI, M.D., M.P.H.", "age": 39, "title": "Chief Medical Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 602737, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ramesh  Ramachandran C.M.A., CPA, M.B.A.", "age": 56, "title": "Chief Accounting Officer, Principal Financial Officer & Principal Accounting Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "John  Kouch J.D.", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany J. Hamilton M.B.A.", "title": "AVP & Head of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristen  Craft", "title": "Head of People & Culture", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Shine M.B.A.", "title": "Senior Vice President of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jyothy  Pillai M.S.", "title": "VP & Head of Regulatory & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 8, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9264, "open": 0.93, "dayLow": 0.93, "dayHigh": 0.966, "regularMarketPreviousClose": 0.9264, "regularMarketOpen": 0.93, "regularMarketDayLow": 0.93, "regularMarketDayHigh": 0.966, "payoutRatio": 0.0, "beta": 4.237, "forwardPE": -3.6807694, "volume": 3251424, "regularMarketVolume": 3251424, "averageVolume": 5629260, "averageVolume10days": 10756530, "averageDailyVolume10Day": 10756530, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 279473664, "fiftyTwoWeekLow": 0.515, "fiftyTwoWeekHigh": 1.979, "priceToSalesTrailing12Months": 61.803112, "fiftyDayAverage": 0.88464, "twoHundredDayAverage": 0.83007, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 277410176, "profitMargins": 0.0, "floatShares": 287364635, "sharesOutstanding": 292031008, "sharesShort": 65193477, "sharesShortPriorMonth": 69595032, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.2232, "heldPercentInsiders": 0.01598, "heldPercentInstitutions": 0.26479, "shortRatio": 11.27, "shortPercentOfFloat": 0.22690001, "impliedSharesOutstanding": 306839008, "bookValue": 0.054, "priceToBook": 17.722221, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -57505000, "trailingEps": -0.2, "forwardEps": -0.26, "lastSplitFactor": "1:60", "lastSplitDate": 1569801600, "enterpriseToRevenue": 61.347, "enterpriseToEbitda": -5.105, "52WeekChange": -0.45157593, "SandP52WeekChange": 0.12677538, "quoteType": "EQUITY", "currentPrice": 0.957, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.5, "targetMedianPrice": 7.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 37800000, "totalCashPerShare": 0.129, "ebitda": -54344000, "totalDebt": 31823000, "quickRatio": 2.239, "currentRatio": 2.604, "totalRevenue": 4522000, "debtToEquity": 199.969, "revenuePerShare": 0.016, "returnOnAssets": -0.61333, "returnOnEquity": -2.48966, "grossProfits": -27945000, "freeCashflow": -27578500, "operatingCashflow": -50904000, "revenueGrowth": 0.461, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -9.79136, "financialCurrency": "USD", "symbol": "OCGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1751576150, "regularMarketTime": 1751562000, "exchange": "NCM", "messageBoardId": "finmb_303874231", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Ocugen, Inc.", "longName": "Ocugen, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1417617000000, "postMarketChangePercent": 1.35841, "postMarketPrice": 0.97, "postMarketChange": 0.013, "regularMarketChange": 0.0306, "regularMarketDayRange": "0.93 - 0.966", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 5629260, "fiftyTwoWeekLowChange": 0.44200003, "fiftyTwoWeekLowChangePercent": 0.8582525, "fiftyTwoWeekRange": "0.515 - 1.979", "fiftyTwoWeekHighChange": -1.022, "fiftyTwoWeekHighChangePercent": -0.5164224, "fiftyTwoWeekChangePercent": -45.157593, "dividendDate": 1569801600, "earningsTimestamp": 1746793800, "earningsTimestampStart": 1754569800, "earningsTimestampEnd": 1754569800, "earningsCallTimestampStart": 1746793800, "earningsCallTimestampEnd": 1746793800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.2, "epsForward": -0.26, "epsCurrentYear": -0.23333, "priceEpsCurrentYear": -4.101487, "fiftyDayAverageChange": 0.07236004, "fiftyDayAverageChangePercent": 0.08179603, "twoHundredDayAverageChange": 0.12693, "twoHundredDayAverageChangePercent": 0.1529148, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 3.30311, "regularMarketPrice": 0.957, "marketState": "CLOSED", "displayName": "Ocugen", "trailingPegRatio": null, "__fetch_time": "2025-07-05"}]